These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17005036)
1. Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias. Jeeninga RE; Jan B; van den Berg H; Berkhout B Retrovirology; 2006 Sep; 3():64. PubMed ID: 17005036 [TBL] [Abstract][Full Text] [Related]
2. Construction of a minimal HIV-1 variant that selectively replicates in leukemic derived T-cell lines: towards a new virotherapy approach. Jeeninga RE; Jan B; van der Linden B; van den Berg H; Berkhout B Cancer Res; 2005 Apr; 65(8):3347-55. PubMed ID: 15833868 [TBL] [Abstract][Full Text] [Related]
3. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. Verhoef K; Marzio G; Hillen W; Bujard H; Berkhout B J Virol; 2001 Jan; 75(2):979-87. PubMed ID: 11134311 [TBL] [Abstract][Full Text] [Related]
4. Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution. Das AT; Klaver B; Centlivre M; Harwig A; Ooms M; Page M; Almond N; Yuan F; Piatak M; Lifson JD; Berkhout B Retrovirology; 2008 Jun; 5():44. PubMed ID: 18533993 [TBL] [Abstract][Full Text] [Related]
5. Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control. Zhou X; Vink M; Berkhout B; Das AT Retrovirology; 2006 Nov; 3():82. PubMed ID: 17094796 [TBL] [Abstract][Full Text] [Related]
6. Construction of Nef-positive doxycycline-dependent HIV-1 variants using bicistronic expression elements. van der Velden YU; Kleibeuker W; Harwig A; Klaver B; Siteur-van Rijnstra E; Frankin E; Berkhout B; Das AT Virology; 2016 Jan; 488():96-107. PubMed ID: 26615334 [TBL] [Abstract][Full Text] [Related]
7. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication. Das AT; Klaver B; Harwig A; Vink M; Ooms M; Centlivre M; Berkhout B J Virol; 2007 Oct; 81(20):11159-69. PubMed ID: 17670816 [TBL] [Abstract][Full Text] [Related]
8. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. Xiao Y; Kuwata T; Miura T; Hayami M; Shida H Virology; 2000 Apr; 269(2):268-75. PubMed ID: 10753705 [TBL] [Abstract][Full Text] [Related]
9. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus. Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392 [TBL] [Abstract][Full Text] [Related]
10. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene. Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912 [TBL] [Abstract][Full Text] [Related]
11. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Marzio G; Verhoef K; Vink M; Berkhout B Proc Natl Acad Sci U S A; 2001 May; 98(11):6342-7. PubMed ID: 11353837 [TBL] [Abstract][Full Text] [Related]
12. Optimization of the Tet-On system for regulated gene expression through viral evolution. Zhou X; Vink M; Klaver B; Berkhout B; Das AT Gene Ther; 2006 Oct; 13(19):1382-90. PubMed ID: 16724096 [TBL] [Abstract][Full Text] [Related]
13. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization. Nagashunmugam T; Friedman HM DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209 [TBL] [Abstract][Full Text] [Related]
14. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. Poon B; Chang MA; Chen IS J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391 [TBL] [Abstract][Full Text] [Related]
15. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine. Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371 [TBL] [Abstract][Full Text] [Related]
17. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. Ghezzi S; Noonan DM; Aluigi MG; Vallanti G; Cota M; Benelli R; Morini M; Reeves JD; Vicenzi E; Poli G; Albini A Biochem Biophys Res Commun; 2000 Apr; 270(3):992-6. PubMed ID: 10772939 [TBL] [Abstract][Full Text] [Related]
20. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. Gibbs JS; Regier DA; Desrosiers RC AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]